Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus.

Science
Share

First published in Expert Opinion on Pharmacotherapy on 2013 Nov.
Expert Opin Pharmacother. 2013 Nov;14(16):2281-96. doi: 10.1517/14656566.2013.838559. Epub 2013 Oct 3.

Authors: Forst T, Pfützner A

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management

LET’S TALK BUSINESS

You May Also Like

Science 30. Januar 2023
Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects.
Science 30. Januar 2023
Midazolam microdosing applied in early clinical development for drug-drug interaction assessment.
Science 30. Januar 2023
The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.